Caffeine/Caffeine and Sodium Benzoate Injection

03 April 2008

Products Affected - Description

Caffeine, anhydrous (121 mg/mL) / Sodium benzoate (129 mg/mL), Bedford
2 mL single-dose vial, package of 10 (NDC 55390-0784-10)

Caffeine, anhydrous (125 mg/mL) / Sodium benzoate (125 mg/mL), American Regent
2 mL single-dose vial, package of 10 (NDC 00517-2501-10)

Reason for the Shortage

Bedford and American Regent state that caffeine and sodium benzoate injection is in short supply due to increased demand for product.

Estimated Resupply Dates

• Bedford has discontinued its product.
• American Regent's product is available.

Related Shortages

• Caffeine Citrate Injection— Resolved

Updated

April 3, 2008; February 25, 2008; February 7, 2008; December 20, 2007; Copyright 2008, University of Utah, Drug Information Service

Back to Drug Shortage Product Bulletins